Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 579 results for "sun pharma advanced research"

Sun Pharma, SPARC up 9-10%; antiepileptic drug gets FDA nod

Shares of Sun Pharmaceutical Industries and Sun Pharma Advanced Research Company (SPARC) rallied 9-10 percent intraday on Wednesday to hit record highs of Rs 1,035 and Rs 448.80, respectively. SPARC, the subsidiary of pharma major, has received approval from ... Money Control, 14 hours ago

6 images for sun pharma advanced research

India Infoline, 1 month ago
Business Standard India, 1 month ago
Sify, 1 day ago
Reuters, 1 day ago
The Week, 1 month ago
Formulary Journal, 1 month ago
Business Standard

Sensex sees profit booking; IT banks drag, pharma rallies

Sun Pharma extended gains in afternoon trade, up 8 percent after its subsidiary Sun Pharma Advanced Research Company received USFDA nod for Elepsia XR extended release tablets, an anti-epileptic drug. It says product will be manufactured by Sun Pharma at ...
 Money Control15 hours ago SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR  Business Standard India17 hours ago Sensex, Nifty erase half of early gains; Sun Pharma up 6%  Money Control17 hours ago Sun Pharma Advanced Research Co Ltd announces USFDA approval of ELEPSIA XR (Levetiracetam) extended-release tablets 1000 mg and 1500 mg  Reuters19 hours ago
[x]  

SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 crore

MUMBAI: Shares of Sun Pharma Advanced Research Company (SPARC), ended the day with gains of nearly 5 per cent, there by adding Rs 440.53 crore to its market capitalisation. SPARC today said it has received approval from the US health regulator for ...
 Economic Times12 hours ago SPARC shares settle with 5 pc gain; mcap up by Rs 440-cr  Business Standard12 hours ago
NDTV Profit

SPARC shares rally 6.5% on USFDA nod for epilepsy drug

Sun Pharma Advanced Research (SPARC) witnessed a rise in share price on Wednesday after it announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for ELEPSIA XR (Levetiracetam extended-release tablets ...
 MyIris16 hours ago SPARC Surges Over 8% on USFDA Nod for Epilepsy Drug  NDTV Profit18 hours ago

SPARC's Elepsia XR tablets receives US FDA approval

Sun Pharma Advanced Research Company Ltd. (SPARC), a wholly owned subsidiary of Sun Pharmaceutical Industries, has received the US Food and Drug Administration (FDA) approval for its New Drug Application (NDA) for Elepsia XR (levetiracetam ...
 PharmaBiz14 hours ago SPARC shines on receiving USFDA approval for ELEPSIA XR extended-release tablets  Arihant Capital19 hours ago SPARC receives USFDA approval for 'ELEPSIA XR' extended-release tablets  Indian-Commodity15 hours ago
Business Standard

Sun Pharma Advanced Research zooms 60% in one week

The stock rallied 13% to Rs 316, extending its past four day's over 40% rally on BSE on back of heavy volumes. SI Reporter | Mumbai January 23, 2015 Last Updated at 10:30 IST Shares of Sun Pharma Advanced Research Company (SPARC) have rallied 13% to Rs 316, ...
 Business Standard1 month ago

Sun Pharma Advanced Research stock hits 20% upper circuit

The stock has hit a high of Rs334 and a low of Rs277.
 India Infoline1 month ago Sun Pharma Advanced stock zooms 18%  India Infoline1 month ago
Business Standard India

SPARC hits record high on heavy volumes

Email this Print Sun Pharma Advanced Research (SPARC) is locked in upper circuit of 20% at Rs 238, also its record high on National Stock Exchange (NSE), on back of heavy volumes. Till 1450 hours, a combined 8.44 million shares representing ...
 Smart Investor1 month ago
Asian Scientist

WuXi PharmaTech Acquires NextCODE For US$65 Million

NextCODE and WuXi's Genome Center will offer comprehensive clinical, research, and diagnostic testing products and services worldwide. Asian Scientist Newsroom | January 27, 2015 | Pharma AsianScientist (Jan. 27, 2015) - WuXi PharmaTech ...
 Asian Scientist1 month ago Chinese Services Group WuXi Buys NextCODE Health for $65m  Bio-IT World1 month ago WuXi PharmaTech Co., Ltd. Acquires NextCode Health To Create Global Leader In Genomic Medicine  BioSpace1 month ago WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine  A.M. Best1 month ago
[x]  

Market Research Reports, Inc. (www.marketresearchreports.com): India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics, New Report Launched

Recent Market Articles 03/02/2015 10:00 AM ET 02/27/2015 10:00 AM ET 02/27/2015 10:00 AM ET Market Research Reports, Inc. has announced the addition of "India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value ...
 BusinessWeek1 day ago India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving Up the Value Chain Beyond Generics, New Report Launched  Digital Journal1 day ago Bharat Book Bureau: India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics  Pharmacy Choice1 week ago Global Anti-counterfeit Packaging Market to Grow at 16.23% CAGR by 2019  Individual.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less